PFBT
PRCT icon

Parkside Financial Bank & Trust’s Procept Biorobotics PRCT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25K Buy
50
+5
+11% +$141 ﹤0.01% 2277
2025
Q4 		$1.42K Buy
+45
New +$1.49K ﹤0.01% 2218
2025
Q3 		– Sell
-21
Closed -$1.21K – 2789
2025
Q2 		$1.21K Buy
21
+11
+110% +$622 ﹤0.01% 2184
2025
Q1 		$583 Buy
+10
New +$683 ﹤0.01% 2296

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parkside Financial Bank & Trust's PRCT Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Procept Biorobotics (PRCT) stake by 11% in Q1 2026, buying an estimated $141 and bringing the position to 50 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Parkside Financial Bank & Trust first reported a position in PRCT in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.42K in Q4 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Parkside Financial Bank & Trust held 50 shares of Procept Biorobotics worth $1.25K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 5 Procept Biorobotics shares in Q1 2026, an estimated $141.
  • Procept Biorobotics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2277 holding.
  • Parkside Financial Bank & Trust first reported a position in Procept Biorobotics in Q1 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Procept Biorobotics position peaked at $1.42K in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.